Cryo Cell International (CCEL) Cash & Current Investments (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Cash & Current Investments data on file, last reported at $2.9 million in Q1 2026.

• Quarterly Cash & Current Investments fell 16.65% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $2.9 million (down 16.65% YoY) and the FY2025 annual result came in at $3.3 million, down 5.72% from the prior year.
• Cash & Current Investments eased to $2.9 million in Q1 2026 per CCEL's latest filing, from $3.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $4.4 million in Q2 2025 and bottomed at $979593.0 in Q1 2024.
• The 5-year median for Cash & Current Investments is $2.6 million (2022), against an average of $2.5 million.
• The widest annual swing landed in 2022, when Cash & Current Investments plunged 79.35%; it then soared 256.66% in 2024.
• Tracing CCEL's Cash & Current Investments over 5 years: stood at $1.7 million in 2022, then plunged by 43.06% to $980250.0 in 2023, then soared by 256.66% to $3.5 million in 2024, then slipped by 5.72% to $3.3 million in 2025, then dropped by 12.01% to $2.9 million in 2026.
• Per Business Quant, the three latest CCEL Cash & Current Investments figures stand at $2.9 million (Q1 2026), $3.3 million (Q4 2025), and $3.2 million (Q3 2025).

Peer Comparison